A quality of life comparison in cyclosporine- And tacrolimus-treated renal transplant recipients across Canada

Journal of Nephrology

Volumn 23, Issue 3, 2010, Pages 274-281

  Prasad, G V Ramesh ^a   Nash, Michelle M ^a   Keough Ryan, Tammy ^b   Shapiro, R Jean ^c  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Calcineurin inhibitors; Health domains; Quality of life; Questionnaire; SF 12; Side effects

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS;

ADULT; ARTHROPATHY; ARTICLE; BLOOD DISEASE; BONE DISEASE; CANADA; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DRUG INDUCED HEADACHE; DRUG PREFERENCE; DRUG RESPONSE; ENTEROPATHY; FEMALE; FOLLOW UP; GRAFT RECIPIENT; GRAFT REJECTION; HAIR DISEASE; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; NEPHROTOXICITY; OBSERVATIONAL STUDY; QUALITY OF LIFE; SCORING SYSTEM; SIDE EFFECT; SKIN TOXICITY; STOMACH IRRITATION; TREMOR; WATER RETENTION; WEIGHT GAIN;

ADULT; AGED; CROSS-SECTIONAL STUDIES; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; QUALITY OF LIFE; TACROLIMUS;

EID: 77951719862     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Fujisawa M, Ichikawa Y, Yoshiya, et al. Assessment of health-related quality of life in renal transplant and hemodialysis patients using the SF-36 health survey. Urology. 2000;56:201-206. (Pubitemid 30495567)
2. Manu MA, Radulescu S, Harza M, et al. Quality of life assessed by SF-36 health survey in renal transplant patients. Transplant Proc. 2001;33:1927-1928. (Pubitemid 32238124)
3. Laupacis A, Keown P, Pus N, et al. A study of the quality of life and cost-utility of renal transplantation. Kidney Int. 1996;50:235-242. (Pubitemid 26323718)
4. Ware JE, Snow KK, Kosinski M. In: SF-36 Health Survey manual and interpretation guide. New York: New England Medical Center; 1993.
5. Butt Z, Yount SE, Caicedo JC, et al. Quality of life assessment in renal transplant: review and further directions. Clin Transplant. 2008;22:292-303. (Pubitemid 351689659)
6. Benedetti E, Matas AJ, Hakim N, et al. Renal transplantation for patients 60 years and older: a single institution experience. Ann Surg. 1994;220:445-448. (Pubitemid 24323441)
7. Bohlke M, Rocha M, Gomes RH, et al. Tacrolimus and quality of life after kidney transplantation-a multicenter study. Clin Transplant. 2006;20:504-508. (Pubitemid 43983831)
8. Cornella C, Brustia M, Lazzarich E, et al. Quality of life in renal transplant patients over 60 tears of age. Transplant Proc. 2008;40:1865-1866.
9. Matas AJ, McHugh L, Payne WD, et al. Long-term quality of life after kidney and simultaneous pancreas-kidney transplantation. Clin Transplant. 1998;12:233-242. (Pubitemid 28269247)
10. Moons P, Vanrenterghem Y, van Hoof JP, et al. Steriods may compromise quality of life of renal transplant recipients on a tacrolimus-based regimen. Transplant Proc. 2002;34:1691-1692.
11. Fiebiger W, Mitterbauer C, Oberbauer R. Health-related quality of life outcomes after kidney transplantation. Health Qual Life Outcomes. 2004;2:1-6. (Pubitemid 39112027)
12. Ware JE, Kosinski M, Keller SD. In: How to score the SF-12 physical and mental health summary scales. Boston, MA: The Health Institute, New England Medical Center; 1995.
13. Jenkinson C, Chandola T, Coulter A, Bruster S. An assessment of the construct validity of the SF-12 summary scores across ethnic groups. J Public Health Med. 2001;23:187-194. (Pubitemid 32895885)
14. Ware J Jr, Kiosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220-233.
15. Jenkinson C, Layte R, Jenkinson D, et al. A shorter form health survey: can the SF-12 replicate results from the SF-36 in longitudinal studies? J Public Health Med. 1997;19:179-186.
16. Prasad GV, Nash MM, McFarlane PA, et al. Renal transplant recipient attitudes towards steroid use and steroid withdrawal. Clin Transplant. 2003;17:135-139.
17. Prasad GV, Nash MM, McFarlane PA, et al. A numerical scale comparison of renal transplant recipient experience with and opinions about calcineurin inhibitors. Nephron Clin Pract. 2004;97:c35-c40.
18. Hopman WM, Towheed T, Anastassiades T, et al. Canadian normative data for the SF-36 health survey. Canadian Osteoporosis Study Research Group. Can Med Assoc J. 2000;163:265-271.
19. Shield CF III. McGrath Mm, Goss TF. Assessment of health-related quality of life in kidney transplant patients receiving tacrolimus (FK506)-based versus cyclosporine-based immunosuppression. FK506 Kidney Transplant Study Group. Transplantation. 1997;64:1738-1743.
20. Reimer J, Franke GH, Philipp T, et al. Quality of life in kidney recipients: comparison of tacrolimus and cyclosporinemicroemulsion. Clin Transplant. 2002;16:48-54. (Pubitemid 34555489)
21. Reimer J, Franke GH, Luetkes P, et al. Quality of life after kidney transplantation: the impact of tacrolimus. Transplant Proc. 2001;33:1924-1926. (Pubitemid 32238123)